Germany v. Dalkon Shield Trust (In Re A.H. Robins Co.)

197 B.R. 525, 1995 Bankr. LEXIS 2062, 1995 WL 862680
CourtDistrict Court, E.D. Virginia
DecidedMarch 9, 1995
Docket85-01307-R
StatusPublished
Cited by11 cases

This text of 197 B.R. 525 (Germany v. Dalkon Shield Trust (In Re A.H. Robins Co.)) is published on Counsel Stack Legal Research, covering District Court, E.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Germany v. Dalkon Shield Trust (In Re A.H. Robins Co.), 197 B.R. 525, 1995 Bankr. LEXIS 2062, 1995 WL 862680 (E.D. Va. 1995).

Opinion

MEMORANDUM

MERHIGE, District Judge, and BLACKWELL N. SHELLEY, Bankruptcy Judge.

This matter came before the Court on March 7, 1995, on a motion by Daikon Shield Claimant Irene Germany, who appears pro se, 1 to vacate an arbitrator’s decision. For *527 the reasons which follow, Movant’s motion will be denied.

I.

Movant is a Daikon Shield claimant who rejected her Option 3 offer and proceeded to arbitration under section E.5(a) of the Claims Resolution Facility (“CRF”). Her ease was heard on September 26-27, 1994. At the hearing, Movant asserted that the Daikon Shield, which she allegedly used from 1974 until 1984, was the cause of various illnesses with which she had been diagnosed, including pelvic inflammatory disease (“PID”), endom-etritis, left hydrosalpinx and a right tubal abscess. As a result of these problems, Mov-ant noted that she underwent a total abdominal hysterectomy and bilateral salpingo-ooph-oreetomy. The Daikon Shield Claimants Trust (“Trust”) argued that Movant’s injuries were caused by her exposure to sexually transmitted diseases.

The Arbitrator considered all of the evidence presented at the hearing, including the testimony of several doctors and experts. He concluded that the Daikon Shield was responsible for some episodes of PID, specifically “chronic endometritis in the uterus, damage to the uterine wall, pain, [and] bleeding.” Movant’s Mem., Arbitrator Decision ¶ 16. He also concluded that the Daikon Shield was the cause of “some vaginal discharge, and some of the emotional distress” claimed by Movant. Id. On the other hand, the Arbitrator also concluded that Movant had a history of exposure to sexually transmitted diseases, and that such exposure was the cause of the “medical conditions in the fallopian tubes and ovaries requiring the complete hysterectomy.” Id. ¶¶ 13-14. On this basis, the Arbitrator awarded Movant $15,000.00.

Movant now challenges this award. Specifically, she advances the following reasons for her appeal: (1) the Arbitrator was biased; (2)the Arbitrator exceeded his powers, or exercised them such that he failed to make a final, definite and unambiguous award; (3) the Arbitrator based the award on evidence outside the clinical record; (4) the form of the award was flawed.

II.

The Arbitration Rules specifically set forth the grounds for vacating an arbitrator’s decision:

(1) The award was produced by corruption, fraud, or undue means.
(2) The arbitrator was biased or corrupt.
(3) The arbitrator was guilty of abuse of discretion in refusing to postpone the hearing, or refusing to admit competent and relevant evidence, or engaging in misconduct that prejudiced the moving party.
(4) The arbitrator exceeded his or her powers, or so exercised them such that he or she failed to make a final, definite, and unambiguous award.

Rules Governing Regular Arbitration, Rule XIV.B. A party seeking to vacate an award must establish at least one of these grounds, all of which are taken from, and interpreted consistently with, parallel provisions in the Federal Arbitration Act. Id. Rules XIV.B & F {citing 9 U.S.C. §§ 9-13); see 9 U.S.C. § 10(a).

This Court, in previously considering a challenge to an arbitrator’s decision, has acknowledged that an arbitrator’s decision receives substantial deference on review, and may only be vacated “upon a showing of one of the grounds listed in the Arbitration Act, or if the arbitrator acted in manifest disregard of the law.” O’Connor v. Dalkon Shield Claimants Trust, 158 B.R. 640 (Bkrtcy.E.D.Va.1993) (citing Wilko v. Swan, 346 U.S. 427, 436-37, 74 S.Ct. 182, 187-88, 98 L.Ed. 168 (1953); Upshur Coals Corp. v. UMWA Dist. 31, 933 F.2d 225, 228 (4th Cir.1991)). 2 Thus, a court may not overturn an arbitration decision merely because it “would have reached a different conclusion if presented with the same facts.” Remmey v. PaineWebber, Inc., 32 F.3d 143, 146 (4th Cir.1994) (citations omitted), cert. denied, *528 U.S. -, 115 S.Ct. 903, 130 L.Ed.2d 786 (1995). Indeed, a reviewing court generally is not to reconsider the arguments and evidence proffered at the hearing; rather, its “role is limited to determining whether the arbitration process itself was flawed.” Id. at 151.

A. Arbitrator’s bias

Movant asserts that the Arbitrator was biased in that he never addressed certain questions regarding causation. Specifically, she proposes that the Arbitrator failed to address whether Movant’s injuries were caused by Chlamydia Trachomatous, as claimed by the Trust, or anaerobic bacteria, as Movant argued. Movant also contends that bias is evidenced through the Arbitrator’s allegedly deficient knowledge of biological science.

“Bias” is defined as a “[condition of [the] mind, which sways judgment and renders [a] judge unable to exercise his functions impartially in [a] particular case.” Blacks Law Dictionary 162 (6th ed.1990). In order to set aside an arbitration award for bias, the Movant must bear the “significant burden” of establishing “specific facts that indicate improper motives on the part of an arbitrator.” Remmey, 32 F.3d at 148. The partiality alleged “must be ‘direct, definite, and capable of demonstration rather than remote, uncertain or speculative.’” Peoples Security Life Ins. Co. v. Monumental Life Ins. Co., 991 F.2d 141, 146 (4th Cir.1993) (quoting Commonwealth Coatings Corp. v. Continental Casualty Co., 393 U.S. 145, 89 S.Ct. 337, 21 L.Ed.2d 301 (1968)).

A review of these principles indicates that Movant has failed to satisfy this weighty burden. As noted above, Plaintiff merely states that the Arbitrator did not address two specific causation-related questions, and that he is not well-versed in biological science. Nowhere does she allege that his decision lacked impartiality. Nor does she contend that the Arbitrator acted with an improper motive. Accordingly, the Court concludes that Movant’s allegations of bias are not well founded.

B. Arbitrator’s exceeding powers

Movant argues that the Arbitrator exceeded his powers in concluding that the majority of Movant’s injuries were caused by her exposure to sexually transmitted diseases.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
197 B.R. 525, 1995 Bankr. LEXIS 2062, 1995 WL 862680, Counsel Stack Legal Research, https://law.counselstack.com/opinion/germany-v-dalkon-shield-trust-in-re-ah-robins-co-vaed-1995.